Tobramix 300 mg Inhalation Solution 5 ml belongs to the class of aminoglycoside antibiotics. Tobramix 300 mg Inhalation Solution 5 ml is used to treat chest infections caused by the bacteria Pseudomonas aeruginosa in cystic fibrosis patients aged six years and older. Pseudomonas aeruginosa is a type of bacteria that can cause lung or chest infections, especially in people who already have a lung disease (cystic fibrosis) or an issue with their immune system.
Tobramix 300 mg Inhalation Solution 5 ml contains Tobramycin, an aminoglycoside antibiotic that fights the infection in your lungs by interfering with protein synthesis in Pseudomonas bacterial cell and helps you breathe better.
Use the Tobramix 300 mg Inhalation Solution 5 ml as prescribed by your doctor. Sometimes, you may experience certain common side effects, such as runny or stuffy nose, sneezing, voice alteration (hoarseness), discolouration of the substance you cough up (sputum), worsening of lung function test results, feeling unwell, muscle pain and voice alteration with sore throat and difficulty swallowing (laryngitis). Most of these side effects do not require medical attention and resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Do not use Tobramix 300 mg Inhalation Solution 5 ml if you are allergic to any of its components or other aminoglycoside antibiotics. Do not use the Tobramix 300 mg Inhalation Solution 5 ml without consulting your doctor if you are pregnant or breastfeeding. Tell your doctor before prescribing Tobramix 300 mg Inhalation Solution 5 ml if you have hearing problems, kidney problems, unusual difficulty breathing with wheezing or coughing, chest tightness, blood in the sputum, muscle weakness, and Parkinson's disease. Tobramix 300 mg Inhalation Solution 5 ml is not recommended to be used in children under the age of six.